| |
| |
|
| Insider
Information: |
Dreyer Scott |
| Relationship: |
EVP & Chief Commercial... |
| City: |
Canton |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
138,918 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$5,142,744 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
138,918 |
|
|
| Total
Value |
$5,142,744 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Collegium Pharmaceutical, Inc |
COLL |
EVP & Chief Commercial... |
2024-02-26 |
138,918 |
2018-07-10 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| COLL |
Collegium Pharmaceutical,... |
EVP & Chief Commercial Officer |
• – – |
2024-02-26 |
4 |
AS |
$36.38 |
$364,270 |
D/D |
(10,000) |
138,918 |
0 |
% |
|
| COLL |
Collegium Pharmaceutical,... |
EVP & Chief Commercial Officer |
• – – |
2024-02-12 |
4 |
D |
$33.70 |
$1,000,553 |
D/D |
(29,690) |
148,918 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
EVP & Chief Commercial Officer |
• – – |
2024-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
67,286 |
178,608 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
EVP & Chief Commercial Officer |
• – – |
2024-01-16 |
4 |
AS |
$32.28 |
$760,519 |
D/D |
(23,560) |
111,322 |
0 |
% |
|
| COLL |
Collegium Pharmaceutical,... |
EVP & Chief Commercial Officer |
• – – |
2023-03-01 |
4 |
AS |
$26.70 |
$355,751 |
D/D |
(13,324) |
134,882 |
0 |
% |
|
| COLL |
Collegium Pharmaceutical,... |
EVP & Chief Commercial Officer |
• – – |
2023-02-10 |
4 |
D |
$26.75 |
$570,471 |
D/D |
(21,326) |
148,206 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
EVP & Chief Commercial Officer |
• – – |
2023-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
66,734 |
169,532 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
EVP & Chief Commercial Officer |
• – – |
2023-01-09 |
4 |
AS |
$27.08 |
$488,554 |
D/D |
(17,834) |
102,798 |
0 |
% |
|
| COLL |
Collegium Pharmaceutical,... |
EVP & Chief Commercial Officer |
• – – |
2022-07-11 |
4 |
D |
$17.48 |
$10,383 |
D/D |
(594) |
120,632 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
EVP & Chief Commercial Officer |
• – – |
2022-02-18 |
4 |
AS |
$21.61 |
$228,180 |
D/D |
(10,559) |
121,226 |
0 |
% |
|
| COLL |
Collegium Pharmaceutical,... |
EVP & Chief Commercial Officer |
• – – |
2022-02-10 |
4 |
D |
$17.63 |
$187,918 |
D/D |
(10,659) |
131,785 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
EVP & Chief Commercial Officer |
• – – |
2022-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
66,175 |
142,444 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
EVP & Chief Commercial Officer |
• – – |
2022-01-10 |
4 |
D |
$19.05 |
$13,354 |
D/D |
(701) |
76,269 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
EVP & Chief Commercial Officer |
• – – |
2021-12-15 |
4 |
AS |
$18.33 |
$104,353 |
D/D |
(5,693) |
76,970 |
0 |
% |
|
| COLL |
Collegium Pharmaceutical,... |
EVP & Chief Commercial Officer |
• – – |
2021-07-12 |
4 |
D |
$23.17 |
$13,786 |
D/D |
(595) |
82,663 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
EVP & Chief Commercial Officer |
• – – |
2021-02-11 |
4 |
AS |
$24.89 |
$199,132 |
D/D |
(7,898) |
83,258 |
0 |
% |
|
| COLL |
Collegium Pharmaceutical,... |
EVP & Chief Commercial Officer |
• – – |
2021-02-10 |
4 |
D |
$25.95 |
$134,525 |
D/D |
(5,184) |
91,156 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
EVP & Chief Commercial Officer |
• – – |
2021-01-19 |
4 |
A |
$0.00 |
$0 |
D/D |
51,945 |
96,340 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
EVP & Chief Commercial Officer |
• – – |
2021-01-15 |
4 |
AS |
$22.89 |
$30,261 |
D/D |
(1,322) |
44,395 |
0 |
% |
|
| COLL |
Collegium Pharmaceutical,... |
EVP & Chief Commercial Officer |
• – – |
2021-01-11 |
4 |
D |
$21.18 |
$14,847 |
D/D |
(701) |
45,717 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
EVP & Chief Commercial Officer |
• – – |
2020-07-13 |
4 |
AS |
$17.01 |
$24,307 |
D/D |
(1,429) |
46,418 |
0 |
% |
|
| COLL |
Collegium Pharmaceutical,... |
EVP & Chief Commercial Officer |
• – – |
2020-07-10 |
4 |
D |
$16.73 |
$9,938 |
D/D |
(594) |
47,847 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
EVP & Chief Commercial Officer |
• – – |
2020-05-18 |
4 |
AS |
$24.00 |
$192,000 |
D/D |
(8,000) |
48,441 |
0 |
% |
|
| COLL |
Collegium Pharmaceutical,... |
EVP & Chief Commercial Officer |
• – – |
2020-05-18 |
4 |
OE |
$15.90 |
$127,200 |
D/D |
8,000 |
56,441 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
EVP & Chief Commercial Officer |
• – – |
2020-05-13 |
4 |
AS |
$22.61 |
$100,253 |
D/D |
(4,434) |
48,441 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
